Cosmos Health reaffirms 2029 guidance
Cosmos Health Inc says it is reaffirming its 2029 guidance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Cosmos Health reaffirms FY 2029 guidance and profit outlook
Cosmos Health reaffirms FY 2029 guidance, expecting $200.60M revenue, $71.20M gross profit, $31M net income and $44.20M adjusted EBITDA.